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Background: Australian bat lyssavirus (ABLV), a rhabdovirus of the genus Lyssavirus which circulates in both
pteropid fruit bats and insectivorous bats in mainland Australia, has caused three fatal human infections, the
most recent in February 2013, manifested as acute neurological disease indistinguishable from clinical rabies.
Rhabdoviruses infect host cells through receptor-mediated endocytosis and subsequent pH-dependent fusion
mediated by their single envelope glycoprotein (G), but the specific host factors and pathways involved in ABLV
entry have not been determined.
Methods: ABLV internalization into HEK293T cells was examined using maxGFP-encoding recombinant vesicular
stomatitis viruses (rVSV) that express ABLV G glycoproteins. A combination of chemical and molecular approaches
was used to investigate the contribution of different endocytic pathways to ABLV entry. Dominant negative Rab
GTPases were used to identify the endosomal compartment utilized by ABLV to gain entry into the host cell cytosol.
Results: Here we show that ABLV G-mediated entry into HEK293T cells was significantly inhibited by the dynamin-specific
inhibitor dynasore, chlorpromazine, a drug that blocks clathrin-mediated endocytosis, and the actin depolymerizing
drug latrunculin B. Over expression of dominant negative mutants of Eps15 and Rab5 also significantly reduced ABLV
G-mediated entry into HEK293T cells. Chemical inhibitors of caveolae-dependent endocytosis and macropinocytosis
and dominant negative mutants of Rab7 and Rab11 had no effect on ABLV entry.
Conclusions: The predominant pathway utilized by ABLV for internalization into HEK293T cells is clathrin-and
actin-dependent. The requirement of Rab5 for productive infection indicates that ABLV G-mediated fusion occurs
within the early endosome compartment.Background
Australian bat lyssavirus (ABLV) is a rhabdovirus of the
genus Lyssavirus endemic in Australian bat populations
that is capable of causing a fatal neurological disease in
humans indistinguishable from clinical rabies. There are
two genetically distinct variants of ABLV: the Pteropus
strain (ABLVp) which circulates in all four species of
frugivorous flying foxes (genus Pteropus) present on
mainland Australia, and the Saccolaimus strain (ABLVs)
present in the insectivorous yellow-bellied sheathtail bat* Correspondence: christopher.broder@usuhs.edu
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unless otherwise stated.(genus Saccolaimus). ABLV has caused three fatal hu-
man infections, the most recent in February 2013, and
each manifested as acute encephalitis; however, incuba-
tion periods were variable, ranging from approximately
5 weeks to over 2 years [1-3]. In May 2013, ABLV in-
fected two horses, representing the first spillover of
ABLV into a terrestrial species other than humans [4,5].
Although the number of ABLV spillover events have
thus far been scarce and limited to only two terrestrial
species, in vitro tropism studies indicate that the un-
known ABLV receptor(s) is broadly conserved among
mammals and suggests that terrestrial species other than
humans and horses may be susceptible to ABLV infec-
tion [6].d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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negative sense RNA virus belonging to the genus Lyssa-
virus of the family Rhabdoviridae within the order
Mononegavirales. There are currently 12 species of lyssa-
viruses and 3 additional species that have not yet been
classified [7]; ABLV is most closely related to classical
rabies virus (RABV), the prototype member of the Lyssa-
virus genus. Lyssaviruses have a single envelope glyco-
protein (G) that mediates all internalization steps from
cell attachment to pH-dependent fusion with the host
cell membrane [8]. The lyssavirus G glycoprotein is a
key determinant of the neurotropic and neurovirulent
properties of lyssaviruses [9].
Rhabdoviruses gain access to the host cell cytoplasm,
the site of viral replication, by receptor-mediated endo-
cytosis and subsequent low pH-dependent fusion [10,11].
Viruses internalized by receptor-mediated endocytosis
predominantly use trafficking pathways mediated either by
clathrin or macropinocytosis, but several alternative path-
ways have been reported (reviewed in [12,13]). Different
viruses utilize different pathways for entry and the endocy-
tic pathway taken by a given virus largely depends on
the host receptor it interacts with and the size of the
virus. Clathrin-mediated endocytosis (CME) is the most
commonly utilized entry pathway for viruses small
and intermediate in size [13] and is the only pathway re-
ported to be utilized by different rhabdoviruses, including
VSV, RABV, and infectious hematopoietic necrosis virus
(IHNV) [14-16]. The initial virus-host cell receptor inter-
action induces de novo clathrin-coated pit (CCP) forma-
tion at the site of viral binding [17,18]. Both VSV and
RABV were shown to internalize through partially coated
clathrin pits that require actin to complete the internaliza-
tion process [15,18]. Entry of IHNV was also shown to be
actin-dependent [14]. After invagination, the CCP buds
from the plasma membrane forming a clathrin-coated
vesicle. The clathrin coat is then shed, enabling the
uncoated vesicle to traffick to and fuse with the early
endosome. The entry pathway of ABLV has not been ex-
amined; however, we recently demonstrated that disrup-
tion of lipid rafts via sequestration of cholesterol by
methyl-β-cyclodextrin (MβCD) treatment significantly re-
duced ABLV G-mediated entry into HEK293T cells [6].
This finding is compatible with a clathrin- or caveolae
-dependent (CavME) entry pathway for ABLV; acute chol-
esterol depletion with MβCD has been shown to inhibit
CCP budding [19] and caveolae formation is strictly
dependent on cholesterol [20].
Once internalized by endocytosis, the acidic environ-
ment of the endosome triggers the conformational
changes in the G glycoprotein that lead to fusion of the
viral and endosomal membranes and the subsequent re-
lease of the viral genome into the cytosol. For most
enveloped viruses, membrane fusion occurs either inearly endosomes (EEs) (pH 6.5-6.0) or late endosomes
(LEs) (pH 6.0-5.0) (reviewed in [12]). Recycling endo-
somes (REs) are responsible for directing vesicular cargo
back to the plasma membrane and have been shown to
be involved in some virus budding pathways [21] and
particle assembly pathways (reviewed in [22]). The use
of dominant negative (DN) Rab GTPases specific for
EEs, LEs, and REs, have been used extensively to deter-
mine virus exit points from the endosomal network
[23-25]. Overexpression of the mutant Rab proteins in
host cells elicits a dominant negative effect over the en-
dogenous wild-type protein; thus, a virus that requires a
specific endosome for trafficking and fusion will be ad-
versely affected by the overexpression of a DN Rab pro-
tein specific for that endosome. Lyssaviruses require
vacuolar acidification for G glycoprotein-mediated viral
and endosomal membrane fusion [10], but few studies
have examined the endosomal trafficking of these vi-
ruses. RABV G was shown to co-localize with Rab5a, a
marker for EEs, but not Rab9, a marker for LEs; this
same study demonstrated that internalization of an anti-
RABV G antibody/RABV G complex was dependent on
the presence of functional Rab5a suggesting that RABV
G fuses with EEs [26]. Furthermore, the optimal pH for
RABV G-mediated fusion is pH 5.8-6.0, which correlates
with the pH of EEs [27]. The membrane fusion require-
ments for ABLV have not been investigated.
In the present study, we used fluorescent protein-
encoding recombinant vesicular stomatitis viruses (rVSV)
that express ABLV G envelope glycoproteins to examine
the ABLV entry pathway using both chemical and molecu-
lar approaches. Results indicate that ABLV is internalized
into HEK293T cells by a clathrin-dependent pathway that
like VSV, IHNV, and RABV, is dependent upon actin.
Moreover, we show that ABLV G-mediated entry is Rab5-
dependent, but Rab7-independent, indicating that ABLV
G-mediated fusion occurs within the early endosomal
compartment.
Results and discussion
Dynamin is required for ABLV G-mediated viral entry
To examine the endocytic pathway utilized by ABLV for
host cell internalization, we used maxGFP-encoding
replication competent recombinant vesicular stomatitis
viruses (rVSV) that express ABLV G glycoproteins [6].
This approach is advantageous over using WT ABLV be-
cause not only are rVSV-ABLV G viruses safer and eas-
ier to manipulate than WT ABLV, but the incorporation
of GFP into the viral genome eliminates the need for
traditional fluorescent antibody staining to detect in-
fected cells. HEK293 cells, an immortalized cell line de-
rived from primary human embryonic kidney cells in the
late 1970s [28], were chosen as the cell culture model to
investigate the ABLV entry pathway. In recent years,
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are typically found only in cells of neuronal origin, dis-
playing neuronal gene expression patterns similar to
those of early differentiating neurons or neuronal stem
cells [29,30]. Moreover, a recent study demonstrated that
HEK293 cells were just as sensitive as murine neuro-
blastoma cells for the rapid isolation of street RABV
from brain tissue of suspected RABV infected animals
[31]. Additionally, we previously demonstrated the high
susceptibility of HEK293T cells to ABLV G-mediated
viral infection [6]. The aforementioned neuronal charac-
teristics of HEK293 cells combined with their ease of
handling, robust growth rate, and amenability to trans-
fection, make them an ideal model to study ABLV entry.
We first examined whether dynamin was required for
ABLV entry. Dynamin, a GTPase that is responsible for
the scission of endocytic vesicles from the plasma mem-
brane [32], plays a critical role in several endocytic path-
ways including, but not limited to, CME [33], CavME
[34], and some types of macropinocytosis [35,36]. In
contrast, dynamin is dispensable for the macropinocytosis
of vaccinia virus (VV) [37], the GPI-anchored protein-
enriched endosomal compartment (GEEC) pathway [38],
and a novel non-clathrin, non-caveolar entry pathway
utilized by lymphocytic choriomeningitis virus (LCMV)
[39]. Therefore, the effect of dynamin inhibition on viral
entry serves as an initial criterion for endocytic pathway
classification.
HEK293T cells were pretreated with dynasore, a spe-
cific and potent inhibitor of dynamin [40], for 30 min at
37°C and then infected with rVSV-ABLV G reporter
viruses; rVSV that expresses VSV G was included as a
positive control. Dynasore treatment of HEK293T cellsFigure 1 Chemical inhibition of dynamin inhibits ABLV G-mediated vi
pretreated with dynasore diluted in OptiMEM® for 30 min at 37°C and were th
Cells were harvested 20 hrs post infection, fixed with 2% paraformaldehyde a
GFP positive cells were counted with a Nexcelom Vision automated cell coun
was calculated by dividing the number of GFP positive cells by the total num
yielded 60-70% virus-infected cells in untreated cells. Drug was maintained fo
determined by trypan blue staining. Reporter viruses that express VSV G were
expressed as percent virus-infected cells relative to that of untreated controls
error of the mean (SEM).inhibited ABLV G-mediated viral entry in a dose
dependent manner, with >80% inhibition at the highest
concentration (Figure 1A). Impaired virus infection was
not due to drug toxicity as cells were >90% viable at the
end of the experiment (Figure 1B). These results indicate
that ABLV G-mediated entry into HEK293T cells follows
a dynamin-dependent pathway.
Inhibition of clathrin-mediated endocytosis inhibits ABLV
G-mediated viral entry
CME is the endocytic route most frequently utilized by
small to intermediate sized viruses to gain entry into
host cells [13]. Other rhabdoviruses such as VSV, IHNV,
and RABV have all been reported to utilize CME for
entry [14-16]. To assess whether clathrin is required for
ABLV entry, we first employed chemical inhibition stud-
ies using chlorpromazine, a drug that inhibits CME by
blocking the assembly of clathrin coated pits [41].
HEK293T cells were pretreated with chlorpromazine at
the indicated concentrations for 30 min at 37°C prior to
infection with rVSV-ABLV G reporter viruses in the
presence of drug; rVSV-VSV G was included as a posi-
tive control. To avoid cell toxicity associated with long-
term exposure to chlorpromazine, cells were harvested
8 hrs post infection and analyzed for GFP expression.
Chlorpromazine inhibited ABLV G-mediated entry in a
dose-dependent manner, with >70% inhibition at the
highest concentration (Figure 2A). To monitor potential
toxic effects of chlorpromazine treatment, cell viability
was assessed in parallel. Under these experimental con-
ditions, no toxicity was noted; greater than 90% of cells
treated with the highest concentration were viable at the
end of the experiment (Figure 2B).ral entry into HEK293T cells. (A) HEK293T cell monolayers were
en infected with max-GFP encoding rVSV reporter viruses (MOI = 1).
nd then analyzed for GFP expression (indicative of productive infection).
ter with fluorescence detection and the percent of virus-infected cells
ber of cells counted. Under these experimental conditions, a MOI of 1
r the entire course of infection and its effect on cell viability (B) was
included as a positive control to assess dynasore activity. Results are
and represent 3 independent experiments; error bars are standard
Figure 2 Chemical inhibition of CME inhibits ABLV G-mediated viral entry into HEK293T cells. (A) HEK293T monolayers were pretreated
with chlorpromazine diluted in OptiMEM® for 30 min at 37°C. Cells were then infected with rVSV (MOI = 3) for 8 hrs and then analyzed as
described in Figure 1. Under these conditions, a MOI of 3 yielded 50-60% virus-infected cells in untreated cells. Drug was maintained for the
entire course of infection and its effect on cell viability (B) was determined by trypan blue staining. The rVSV-VSV G reporter virus was included
as positive control. Results are expressed as percent virus-infected cells relative to that of controls and represent 3 independent experiments;
error bars are SEM.
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next examined the effect of the expression of a dominant
negative (DN) mutant (EH29) of the CME effector pro-
tein Eps15. The EH29 mutant blocks CME by preventing
clathrin-coated pit formation and does not affect non-
clathrin pathways; Eps15 mutant DIIIΔ2, which has no
effect on clathrin-coated pit assembly, was included as a
negative control for the inhibition of CME [42-44].
HEK293T cells were transfected with plasmids encoding
eGFP alone or eGFP-tagged Eps15 mutants for 18 hrs;
transfection rates, as measured by eGFP expression, con-
sistently reached 50-60% (data not shown). Cells were
then infected with VSVΔG-RFP pseudoviruses that ex-
press ABLV G or VSV G at a MOI = 2. After 20 hrs the
cells were harvested and analyzed for RFP expression.
Representative microscopic fields of cells transfected
with each Eps15 construct and infected with VSVΔG-
ABLVp G*- RFP pseudovirus are shown in Figure 3A.
Similar results were obtained for ABLVs G-expressing
pseudovirus (not shown). As expected, compared to the
eGFP control, DIIIΔ2 did not interfere with ABLV entry
(Figure 3B); however, ABLV G-mediated viral entry was
significantly inhibited by EH29 (60%) compared to eGFP
controls (Figure 3B). The uptake of cholera toxin B sub-
unit (CTX-B), which is endocytosed by CavME [45], was
not inhibited by EH29, demonstrating the specificity of
EH29 in inhibiting CME (Figure 3C). Taken together,
these data suggest that ABLV G-mediated viral entry
into HEK293T cells occurs through a clathrin-dependent
pathway.
Caveolar-dependent endocytosis and macropinocytosis
are not involved in ABLV G-mediated viral entry
Some viruses, such as Ebola virus [46,47], influenza A
[48,49], and reovirus [50], have been reported to utilize
more than one type of endocytic pathway to gain entryinto host cells. Additionally, we previously showed that
the disruption of lipid rafts through cholesterol deple-
tion significantly reduced ABLV G-mediated entry into
HEK293T cells [6], a finding compatible with a clathrin-
or caveolae-dependent entry pathway. To test the pos-
sible contribution of pathways other than CME to ABLV
G-mediated viral entry, HEK293T cells were treated with
the chemical inhibitors filipin and EIPA (5-(N-ethyl-N-
isopropyl amiloride)) to inhibit CavME and macropino-
cytosis, respectively. A recombinant VSV reporter virus
expressing VSV G and fluorescently labeled CTX-B were
included as a negative and positive control, respectively
for CavME [45]; rVSV-EboGP reporter virus was in-
cluded as a positive control for macropinocytosis [47].
Pretreatment of HEK293T cells with filipin, which disrupts
CavME by specifically binding to cholesterol abundant
in caveolae [51,52], did not inhibit ABLV G-mediated
entry (Figure 4A), but did significantly decrease the uptake
of CTX-B into HEK293T cells (Figure 4B). Similarly,
pretreatment of HEK293Tcells with EIPA, a potent inhibi-
tor of Na+/H+ exchanger activity required for macro-
pinosome formation [53,54], had no effect on ABLV
G-mediated entry but, as previously reported, drastically
inhibited Ebo GP-mediated viral entry (>98%) (Figure 4C)
[47]. Taken together, these data indicate that CavME and
macropinocytosis do not contribute to ABLV G-mediated
entry into HEK293T cells. This is in agreement with previ-
ous studies that show that CavME and macropinocytosis
do not play a role in the entry of other rhabdoviruses
[14,15,47].
Actin polymerization is required for ABLV G-mediated
viral entry
Recent studies have revealed that the rhabdoviruses
VSV, RABV, and IHNV are internalized through cla-
thrin-dependent pathways that are also actin-dependent
Figure 3 Inhibition of CME with a DN form of Eps15
significantly reduces ABLV G-mediated viral entry into HEK293T
cells. HEK293T cells transfected with an eGFP control plasmid or eGFP-
tagged Eps15 mutants were infected with VSVΔG-ABLV G* or –VSV
G*-RFP pseudoviruses at a MOI = 2 for 20 hrs and then analyzed for RFP
expression as described in Figure 1. Under these conditions, a MOI of
2 yielded 25-30% virus-infected cells among cells transfected with the
eGFP control plasmid. DIIIΔ2, a mutant of Eps15 that does not affect
clathrin coated pit formation; EH29, DN Eps15 mutant. (A) Representa-
tive microscopic fields of cells transfected with each Eps15 construct
and infected with VSVΔG-ABLVp G*- RFP pseudovirus. Similar results
were obtained for ABLVs G-expressing pseudovirus (not shown).
(B) Quantitation of virus-infected cells. A minimum of 1000 cells were
counted for each sample per experiment. VSVΔG- VSV G* was included
as positive control. Results are expressed as percent virus-infected cells
relative to that of controls and represent 3 independent experiments;
error bars are SEM. Significance of effect on virus infection was deter-
mined using Student’s t-test. **, p < 0.0005; *, p < 0.005. (C) Cholera toxin
B (CTX-B) subunit uptake into HEK293T cells is not inhibited by EH29.
To verify the specificity of EH29 to inhibit CME, 18 hrs post transfection
HEK293T cell monolayers grown on 12 mm coverslips were incubated
with Alexa Fluor 594-labeled CTX-B (10 μg/ml) for 1 hr at 37°C. Cells
were then washed twice with PBS, fixed and imaged. Images were
taken by confocal microscopy with a mid z-section shown. Nuclei were
stained with DAPI (4′,6-diamidino-2-phenylindole, dihydrochloride).
Figure 4 CavME endocytosis and macropinocytosis are not
required for ABLV G-mediated viral entry. (A) Chemical inhibition
of CavME. HEK293T cell monolayers were pretreated with filipin
diluted in OptiMEM® for 1 hr at 37°C. Cells were then infected with
rVSV (MOI = 1) for 20 hrs and analyzed as described in Figure 1.
Drug was maintained for the entire course of infection. (B) Cholera
toxin B (CTX-B) subunit uptake is inhibited by filipin. Following
pretreatment with filipin as described in (A), HEK293T cell monolayers
grown on 12 mm coverslips were incubated with Alexa Fluor 488-
labeled CTX-B (10 μg/ml) for 1 hr at 37°C. Cells were then washed twice
with PBS, fixed and imaged. Images were taken by confocal
microscopy with a mid z-section shown. Nuclei were stained with
DAPI, (4′,6-diamidino-2-phenylindole, dihydrochloride). (C) Chemical
inhibition of macropinocytosis. HEK293T cell monolayers were pre-
treated with EIPA diluted in OptiMEM® for 1 hr at 37°C. Cells were then
infected with rVSV (MOI = 1) for 20 hrs and analyzed as described in
Figure 1. rVSV encoding VSV G (MOI = 1) or EboGP (MOI = 15) were
included as negative and positive controls, respectively, to assess EIPA
activity. Drug was maintained for the entire course of infection. For
(A) and (C) results are expressed as percent virus-infected cells relative
to that of untreated controls and represent 3 independent experi-
ments; error bars are SEM. Under these experimental conditions, the
chosen MOIs yielded 60-70% virus-infected cells in untreated controls.
EIPA, 5-(N-ethyl-N-isopropyl) amiloride.
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dependent upon actin, HEK293T cells were pretreated
with the actin depolymerizing drug latrunculin B (LatB)
at the indicated concentrations for 1 hr at 37°C prior to
infection with rVSV-ABLV G reporter viruses in the
presence of drug; rVSV-VSV G was included as a posi-
tive control. To avoid cell toxicity associated with long-
term exposure to LatB, cells were harvested 8 hrs post
infection and analyzed for GFP expression. LatB signifi-
cantly inhibited ABLV G-mediated entry at all concen-
trations tested with greater than 65% and 90% inhibition
of ABLVs G- and ABLVp G-mediated entry, respectively,
at the highest concentration tested (Figure 5A). Entry in-
hibition was not due to drug toxicity as cell viability
remained greater than 85% at the highest dose of LatB
(Figure 5B).
Actin is not required for the clathrin-mediated uptake
of transferrin, the classical ligand used to study CME
[15,55]; however, it is required for CME of large cargos
such as viruses and bacteria [15,18,56]. VSV and RABV
in particular have been shown to be internalized by par-
tially coated pits that require actin polymerization for
envelopment; this dependence on actin is dictated by the
size of the particle, as truncated defective-interfering
particles of VSV do not require actin [15,18,57]. Thus,
given the shared particle morphology of all rhabdovi-
ruses, it is not surprising that ABLV entry is also actin-
dependent. The mechanism by which cell surface bound
viral particles induce actin recruitment to the CCPs is
not completely understood. However, recent studies have
demonstrated that plasma membrane tension induces the
actin dependence of clathrin coat assembly; in the case of
tense or rigid membranes, actin polymerization may be re-
quired to produce sufficient force to complete membrane
deformation into a coated pit prior to the recruitment of
dynamin and subsequent vesicle budding [58,59]. It hasFigure 5 Actin is required for ABLV G-mediated viral entry. (A) HEK293
OptiMEM® for 1 hr at 37°C. Cells were then infected with max-GFP encodin
yielded at least 50% virus-infected cells in untreated controls. Cells were ha
Drug was maintained for the entire course of infection and its effect on ce
that express VSV G were included as a positive control to assess LatB activi
of untreated controls and represent 3 independent experiments; error barsbeen postulated that upon cell surface binding, the viral
particles themselves induce membrane tension, thus lead-
ing to the recruitment of actin to the forming clathrin-
coated vesicle [15,18,57,58].
Rab5, but not Rab7 or Rab11, is required for ABLV
G-mediated viral entry
The above data indicate that ABLV G-mediated viral
entry into HEK293T cells occurs through a clathrin- and
actin-dependent pathway. To investigate the subsequent
trafficking route to the site of cytosol penetration, we ex-
amined the roles in ABLV entry of the small GTPases
Rab5, Rab7, and Rab11, which are involved in vesicular
trafficking to early, late, and recycling endosomes, respect-
ively [12]. HEK293T cells were transfected with RFP-
tagged dominant negative (DN) forms of Rab5 (S34N)
[60], Rab7 (T22N) [61], and Rab11 (S25N) [62], which pre-
vent the fusion of endocytic vesicles with early endosomes,
prevent movement from early to late endosomes, and
prevent movement from early to recycling endosomes,
respectively. Transfected cells were infected with rVSV-
ABLV G 18–20 hrs post-transfection. Cells were fixed
8 hrs later and analyzed for GFP expression. Reporter vi-
ruses that express VSV G and Ebo GP were included as
positive controls for Rab5 and Rab7, respectively [25,47].
As shown in Figure 6A, expression of the Rab5 DN
significantly reduced (p < 0.005) ABLV G-mediated viral
entry compared to Rab5 WT, with greater than 40%
inhibition for both ABLV variants (Figure 6A); as previ-
ously reported, both VSV G- and Ebo GP-mediated
entry was significantly inhibited by Rab5 DN (p < 0.0001)
(Figure 6A) [23,25,47]. Expression of Rab7 DN and Rab11
DN did not inhibit ABLV G-mediated viral entry, but ra-
ther enhanced infection compared to Rab7 and 11 WT
plasmids (Figure 6B-C); however, the increase in infectivity
was not statistically significant. Expression of the Rab7T cell monolayers were pretreated with latrunculin B (LatB) diluted in
g rVSV reporter viruses (MOI = 3). Under these conditions, a MOI of 3
rvested 8 hrs post infection and analyzed as described in Figure 1.
ll viability (B) was determined by trypan blue staining. Reporter viruses
ty. Results are expressed as percent virus-infected cells relative to that
are standard error of the mean (SEM).
Figure 6 Effect of dominant negative Rab GTPases on ABLV
G-mediated viral entry. HEK293T cells expressing dsRed-tagged WT
and DN Rab5, Rab7, and Rab11were infected with maxGFP encoding
rVSV that express ABLVp G, ABLVs G, or VSV G at a MOI = 3 for 8 hrs
or with rVSV that expresses EboGP at a MOI = 15 for 20 hrs and then
analyzed as described in Figure 1. Infection of all cells was assessed.
Under these conditions, the chosen MOIs yielded 40-50% virus-infected
cells in controls. Results are expressed as percent virus-infected cells
relative to that of WT Rab controls and represent 3 independent
experiments; error bars are SEM. (A) Rab5. (B) Rab7. (C) Rab11.
**, p < 0.0001; *, p < 0.005.
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as Ebo GP-mediated viral entry was significantly inhibited
(p < 0.0001) (Figure 6B) [47]. In agreement with previous
studies, VSV G-mediated viral entry was not inhibited by
DN mutants of Rab7 and 11 (Figure 6B-C) [25]. Similar to
results for ABLV G-mediated infection, the apparent in-
creased VSV infectivity of cells expressing DN Rab7 and11 mutants compared to cells expressing WT Rabs was
not statistically significant.
Rab11 is required for the transport of cargo from the
Trans-Golgi network to the plasma membrane [63] and
has been shown to play roles in virus assembly/budding
[21,22]; however, consistent with our findings, there have
been no reports of Rab11 playing a role in viral entry.
Nevertheless, both VSV G and RABV G have been
shown to colocalize with Rab11 [26,63] and the expres-
sion of the Rab11 DN has previously been shown to lead
to accumulation of VSV G in the Golgi [63]. These stud-
ies suggest that Rab11 may play a post-entry role in traf-
ficking of newly synthesized G from the Golgi to the
plasma membrane. It is possible that a similar role for
Rab11 in ABLV G trafficking exists, however this has
not been investigated. Collectively, these data indicate
that ABLV G-mediated fusion of viral and host cell
membranes is triggered upon delivery to early endo-
somes and that productive ABLV infection does not re-
quire transfer to late or recycling endosomes. Further
supporting this argument, and similar to that of RABV
G [27], ABLV G-mediated fusion occurs at pH 6.0-6.2
with optimal fusion between pH 5.7–5.9 (data not
shown), which correlates with the pH of EEs [12].Conclusions
In summary, we have used both chemical and molecular
approaches to examine the entry pathway utilized by
ABLV for internalization into HEK293T cells. The results
presented here reveal that ABLV G-mediated viral entry
primarily follows a clathrin-dependent pathway that,
similar to other rhabdoviruses including RABV, requires
actin for productive infection. Moreover, we show that
productive ABLV infection is dependent upon Rab5, but
not Rab7 or Rab11, indicating that the mildly acidic en-
vironment of the early endosome is sufficient to trigger
ABLV G-mediated viral and endosomal membrane fu-
sion and subsequent release of the viral genome into the
cytosol.
The identification of specific entry requirements for a
given virus is an important first step towards the devel-
opment of antivirals capable of blocking infection. This
study is the first to identify specific host factors required
for ABLV entry. Our ongoing studies are aimed at
identifying additional host factors required for ABLV in-
fection using a high-throughput siRNA screening ap-
proach. Based on the results presented here, which
indicate that ABLV follows a similar entry pathway as
RABV [15], it is possible that the identification of host
factors required for ABLV infection will provide poten-
tial targets for the development of therapeutics with the
potential of broadspectrum activity against other lyssa-
virus species.
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Cells and viruses
HEK293T cells were provided by Gerald Quinnan (Uni-
formed Services University) and were maintained in Dulbec-
co’s modified Eagle’s medium (DMEM; Quality Biologicals,
Gaithersburg, MD) supplemented with 10% cosmic calf
serum (CCS) (Hyclone, Logan, UT) and 2 mM L-glutamine
(DMEM-10). Recombinant maxGFP expressing vesicular
stomatitis viruses (rVSV) that express ABLV G, Ebola Zaire
GP, and VSV (Indiana) G glycoproteins have been previously
described [6]. VSVΔG-G*-RFP pseudovirus stocks were
kindly provided by Michael Whitt (University of Tennessee).
VSVΔG pseudoviruses complemented with ABLV G glyco-
proteins were prepared by transfecting HEK293T cells with
expression plasmids that express ABLVs G and ABLVp G
[6]. Twenty four hours after transfection, cells were infected
with VSVΔG-G*-RFP at a multiplicity of infection (MOI) of
1 for 1 hr at 37°C. The cells were then washed three times
with phosphate buffered saline (PBS) and DMEM-10 was
added. After 24 hrs, culture supernatant was collected and
cell debris was removed by centrifugation at 2,600 rpm for
10 min. Clarified supernatant was layered on top of 20%
sucrose in TNE buffer (10 mM Tris, 135 mM NaCl,
2 mM EDTA) and centrifuged at 27,000 rpm for 2 hrs.
Pseudovirus pellets were resuspended in 10% sucrose/
TNE buffer. Viral titers were determined by adding serial
10-fold dilutions of virus to HEK293T cells grown on
96-well plates. At 24 hrs post-infection, fluorescent cells
were counted under a fluorescent microscope and calcu-
lated as infectious units/ml (IU/ml).
Drug treatments and cell infection assays
All chemical inhibitors were purchased from Sigma
(St. Louis, MO). Stock solutions were prepared in water
(chlorpromazine) or DMSO (dynasore, filipin, EIPA
[5-(N-ethyl-N-isopropyl) amiloride], and latrunculin B)
and stored, as per manufacturer’s recommendation.
HEK293T cells were pretreated for 30 min in the pres-
ence of dynasore or chlorpromazine or for 1 hr in the
presence of filipin, EIPA, or latrunculin B (LatB) at the
indicated concentrations and then infected with rVSV
viruses (rVSV-ABLV G and -VSV G, MOI = 1 or 3 for
20 hr and 8 hr infections, respectively; rVSV-EboGP,
MOI = 15). Under these experimental conditions, the
above MOIs resulted in 60-70% or 50-60% virus-infected
cells in untreated controls for 20 hr and 8 hr infections,
respectively. All drugs and viruses were diluted in Opti-
MEM® (Invitrogen, Carlsbad, CA) and drugs were main-
tained for the entire course of infection. Cells were
harvested 20 hrs post infection (p.i.) for dynasore, filipin,
and EIPA treatments, and 8 hrs p.i. for chlorpromazine
and latrunculin B treatments. Single-cell preparations
were made and fixed (2% paraformaldehyde (PFA) in
PBS) and GFP expression, indicative of productiveinfection, was analyzed by a Nexcelom Vision automated
cellometer (Nexcelom Bioscience LLC., Lawrence, MA)
capable of fluorescence detection. The percent of in-
fected cells was calculated by dividing the number of
GFP positive cells by the total number of cells and
multiplying by 100. At least 1000 cells were counted per
sample for each experiment. Results are expressed as
percent virus-infected cells relative to that of untreated
controls and represent 3 independent experiments; error
bars are standard error of the mean (SEM). Cell viability
of drug treated cells was determined by trypan blue
staining.
Analysis of dominant negative mutants of Eps15, Rab5,
Rab 7, and Rab11
Eps15 control (DIIIΔ2) and dominant negative (DN)
(EH29) eGFP-tagged plasmids were kindly provided
by Robert Davey (Texas Biomedical Research Institute).
A plasmid expressing eGFP (pEGFP-C1; Clonetech,
Mountain View, CA) was used as an additional control
in Eps15 experiments. DsRed-tagged Rab7 wild-type
(WT) (plasmid #12661) and DN (T22N; plasmid #12662),
DsRed-tagged Rab11 WT (plasmid #12679) and DN
(S25N; plasmid #12680) [64], and mRFP-tagged Rab5 WT
(plasmid #14437) [65] were purchased from Addgene,
Cambridge, MA. RFP-tagged Rab5 DN (S34N) was gener-
ated by site-directed mutagenesis of Rab5 WT using a
QuikChange II site-directed mutagenesis kit (Stratagene,
Cedar Creek, TX). HEK293T cells grown to 50% conflu-
ence in 24-well tissue culture plates were transfected with
plasmids using Lipofectamine LTX (Invitrogen) according
to the manufacturer’s protocol. Eighteen to twenty hours
post transfection, cells were infected with VSVΔG-ABLV
G*-RFP at a MOI = 2 for 20 hrs (Eps15 transfected cells)
or with rVSV-ABLV G-GFP at a MOI = 3 for 8 hrs (Rab
transfected cells). VSVΔG-VSV G*-RFP (MOI = 2) was in-
cluded as a positive control for Eps15 DN functionality.
Recombinant VSV-GFP reporter viruses that express VSV
G (MOI = 3, 8 hr infection) and EboGP (MOI = 15, 20 hr
infection) were included as positive controls for Rab5 DN
and Rab7 DN functionality, respectively. Under these ex-
perimental conditions, the chosen MOIs yielded 25-30%
and 40-50% virus-infected cells in controls for the Eps15
and Rab experiments, respectively. Cells were harvested
and analyzed for RFP or GFP expression (Eps15 and
Rab experiments, respectively) using a Nexcelom Vision
cell counter as described above. At least 1000 cells were
counted per sample per experiment. Results are expressed
as percent virus-infected cells relative to that of controls
and represent 3 independent experiments; error bars
are SEM. For confocal imaging, HEK293T cells grown to
30% confluence on 12 mm coverslips were transfected
and infected as described above. Cells were fixed with
4% PFA and then the coverslips mounted on slides using
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media and imaged by confocal microscopy.
Cholera toxin B subunit uptake
HEK293T cells grown on 12 mm coverslips in 24-well tis-
sue culture plates were pretreated with filipin or transfected
with Eps15 plasmids as described above and then incubated
with Alexa Fluor (AF) 488- or AF 594-conjugated cholera
toxin B subunit (Invitrogen) (10 μg/ml) diluted in Opti-
MEM® for 1 hr at 37°C. Cells were washed twice with PBS
and fixed with 4% PFA. The coverslips were mounted on
slides using SouthernBiotech™ Dapi-Fluoromount-G™ clear
mounting media and imaged by confocal microscopy.
Confocal microscopy
Confocal images were obtained using a 63× oil objective,
a Zeiss 710 NLO microscope, and Zen software. LSM
files were exported to Adobe Photoshop for cropping
and contrast adjustments.
Statistical analysis
Student’s t-test was used to evaluate the statistical sig-
nificance levels of the data, with p < 0.05 indicating stat-
istical significance.
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